best quality practices for biomedic research: rick calabrese asq 2014 ne conference
DESCRIPTION
ASQ Technical Report Quality Practices in Biomedical Research and Drug DevelopmentTRANSCRIPT
![Page 1: Best Quality Practices for Biomedic Research: Rick Calabrese ASQ 2014 NE Conference](https://reader033.vdocuments.mx/reader033/viewer/2022052601/5597a14f1a28aba7098b46c8/html5/thumbnails/1.jpg)
Best Quality Practices for Biomedical Research in Drug Development
Rick Calabrese Global Director of Quality Systems Sartorius Stedim Biotech 15 Jan 2014
1
ASQ Northeast Pharmaceutical GMP Conference 2014
![Page 2: Best Quality Practices for Biomedic Research: Rick Calabrese ASQ 2014 NE Conference](https://reader033.vdocuments.mx/reader033/viewer/2022052601/5597a14f1a28aba7098b46c8/html5/thumbnails/2.jpg)
Table of Contents
• Project Background • Purpose of Technical Report • Project Goals • Objectives • Current Technical Report Outline • Management System • Documentation • Technical Requirements • Legal & Ethical Considerations • Dependencies & Resources • Contributors & Affiliation • Looking Ahead • Questions
Best Quality Practices for Biomedical Research in Drug Development
2
![Page 3: Best Quality Practices for Biomedic Research: Rick Calabrese ASQ 2014 NE Conference](https://reader033.vdocuments.mx/reader033/viewer/2022052601/5597a14f1a28aba7098b46c8/html5/thumbnails/3.jpg)
Project Background
Best Quality Practices for Biomedical Research in Drug Development
• Recent basic science achievements promise significant payoffs in human health, but these potential benefits are threatened by low productivity -- measured by the high costs and high risks of failure in the current development processes and the declining number of successful products reaching patients.”
• FDA’s “Critical Path Paper”, March 2004
3
![Page 4: Best Quality Practices for Biomedic Research: Rick Calabrese ASQ 2014 NE Conference](https://reader033.vdocuments.mx/reader033/viewer/2022052601/5597a14f1a28aba7098b46c8/html5/thumbnails/4.jpg)
Project Background
• Because of the rapid progress of biological sciences, non-GLP laboratory research (e.g. biomarker development, exploratory, mechanistic studies etc.) has become increasingly critical for modern drug development.
• Many research institutions are recognizing the need to establish solid quality standards to ensure integrity and validity of the data they generate. But which standards and how to introduce them is the big question.
4
![Page 5: Best Quality Practices for Biomedic Research: Rick Calabrese ASQ 2014 NE Conference](https://reader033.vdocuments.mx/reader033/viewer/2022052601/5597a14f1a28aba7098b46c8/html5/thumbnails/5.jpg)
Project Background
• Non-GLP biomedical research has traditionally been considered to be off-limits for formal quality systems or management.
• Scientists in general regard their work as a highly intellectual activity where quality is a knowledge and experience driven integral part of the scientific rigor they apply.
• A long-standing tradition of quality control in science has been peer review of the results, but modern pharmaceutical research has become so complex that peer review has a limited value today.
Best Quality Practices for Biomedical Research in Drug Development
5
![Page 6: Best Quality Practices for Biomedic Research: Rick Calabrese ASQ 2014 NE Conference](https://reader033.vdocuments.mx/reader033/viewer/2022052601/5597a14f1a28aba7098b46c8/html5/thumbnails/6.jpg)
Purpose of Technical Report
• To minimize waste of resources and reduce the need for costly confirmation and repetition of work already performed
• To generate reliable data to ensure a solid basis for deciding whether to invest in further development of a strategy or product
• Quality means better science
Best Quality Practices for Biomedical Research in Drug Development
6
![Page 7: Best Quality Practices for Biomedic Research: Rick Calabrese ASQ 2014 NE Conference](https://reader033.vdocuments.mx/reader033/viewer/2022052601/5597a14f1a28aba7098b46c8/html5/thumbnails/7.jpg)
• The technical report specifies the general quality requirements for non-regulated biomedical research in drug development in order to ensure credibility of biomedical research results.
• This includes both large and small molecule discovery and non-clinical development that is not covered by GxP.
• It is based on the format laid out for the international quality management standard ISO 9001.
Technical Report Project
Best Quality Practices for Biomedical Research in Drug Development
7
![Page 8: Best Quality Practices for Biomedic Research: Rick Calabrese ASQ 2014 NE Conference](https://reader033.vdocuments.mx/reader033/viewer/2022052601/5597a14f1a28aba7098b46c8/html5/thumbnails/8.jpg)
Project Goals
• The target audience for this technical report is the scientific staff at institutions and companies involved in drug development.
• Compliance with applicable regulatory and safety requirements are not covered by this report.
• Set up basic quality standards for new drug development.
Best Quality Practices for Biomedical Research in Drug Development
8
![Page 9: Best Quality Practices for Biomedic Research: Rick Calabrese ASQ 2014 NE Conference](https://reader033.vdocuments.mx/reader033/viewer/2022052601/5597a14f1a28aba7098b46c8/html5/thumbnails/9.jpg)
Objectives
• Publish ASQ Technical Report (Completed June 2012) • Publish the technical report Mandarin and Spanish • Present information to targeted groups • Publish promotional papers in ASQ journals and other magazines • Provide training courses on the information in the technical
report • Initiate joint forums with WHO and regulatory agencies (FDA,
EMA, Health Canada, SFDA, etc.) for their input and by in. • Develop the technical report into an ASQ/ANSI standard • Turn the ASQ/ANSI standard into an internationally recognized
ISO standard.
Best Quality Practices for Biomedical Research in Drug Development
9
![Page 10: Best Quality Practices for Biomedic Research: Rick Calabrese ASQ 2014 NE Conference](https://reader033.vdocuments.mx/reader033/viewer/2022052601/5597a14f1a28aba7098b46c8/html5/thumbnails/10.jpg)
Current Technical Report Outline
• Management System • Documentation • Technical Requirements • Legal and ethical considerations
Best Quality Practices for Biomedical Research in Drug Development
10
![Page 11: Best Quality Practices for Biomedic Research: Rick Calabrese ASQ 2014 NE Conference](https://reader033.vdocuments.mx/reader033/viewer/2022052601/5597a14f1a28aba7098b46c8/html5/thumbnails/11.jpg)
Management System
• Have managerial and scientific personnel to carry
out their duties
• Have arrangements and / or policies to ensure that
it may not adversely affect the quality of their work
• Appoint a member of staff as quality manager who
has direct access to the highest level of the research
institute’s management at which decisions are made
on research institution policy or resources
• Have facilities and equipment sufficient to conduct
the study
Best Quality Practices for Biomedical Research in Drug Development
11
![Page 12: Best Quality Practices for Biomedic Research: Rick Calabrese ASQ 2014 NE Conference](https://reader033.vdocuments.mx/reader033/viewer/2022052601/5597a14f1a28aba7098b46c8/html5/thumbnails/12.jpg)
• Prescriptive documents typically include Standard Operating Procedures (SOPs), methods, study plans or protocols.
• They are critical for ensuring data quality and integrity as well as overall repeatability of the research work.
• Descriptive documents include batch records, reports and forms. • All laboratory activities should be documented to contain
sufficient detail to allow replication of the original work. • Ensure traceability by identifying raw data, calculations,
identification numbers for samples, reagents, reference standards, etc.
• Non-conforming results should be clearly identified and fully explained in the primary record.
• Deviations should be investigated explaining their impacts on the study.
Best Quality Practices for Biomedical Research in Drug Development
Documentation
12
![Page 13: Best Quality Practices for Biomedic Research: Rick Calabrese ASQ 2014 NE Conference](https://reader033.vdocuments.mx/reader033/viewer/2022052601/5597a14f1a28aba7098b46c8/html5/thumbnails/13.jpg)
Documentation
• Research institutions should establish procedures for the control of prescriptive and descriptive documents.
• Procedures should include a formal review and approval. • Only the most recent approved documents are available for
staff use. • The research institution should establish and maintain a
change control process. • Documents should be stored in a secure and suitable
environment that provides confidentiality and prevention from loss, deterioration and destruction.
Best Quality Practices for Biomedical Research in Drug Development
13
![Page 14: Best Quality Practices for Biomedic Research: Rick Calabrese ASQ 2014 NE Conference](https://reader033.vdocuments.mx/reader033/viewer/2022052601/5597a14f1a28aba7098b46c8/html5/thumbnails/14.jpg)
Technical Requirements
• Personnel • Facility and Infrastructure • Test Equipment • Equipment Design • Calibration • Test Methods • Method Validation • Sampling and Chain of Custody • Materials • Test Articles, Control Articles, and Test Systems
Best Quality Practices for Biomedical Research in Drug Development
14
![Page 15: Best Quality Practices for Biomedic Research: Rick Calabrese ASQ 2014 NE Conference](https://reader033.vdocuments.mx/reader033/viewer/2022052601/5597a14f1a28aba7098b46c8/html5/thumbnails/15.jpg)
Personnel
• Training is critical to develop and maintain competence.
• All personnel should be made aware of the importance of training and its impact on the quality objectives.
• Training should be carried out by personnel with appropriate skills, qualifications and experience.
• Records are typically kept to document the qualifications of the personnel used as trainers.
Best Quality Practices for Biomedical Research in Drug Development
15
![Page 16: Best Quality Practices for Biomedic Research: Rick Calabrese ASQ 2014 NE Conference](https://reader033.vdocuments.mx/reader033/viewer/2022052601/5597a14f1a28aba7098b46c8/html5/thumbnails/16.jpg)
Facility and Infrastructure
• Buildings and workspace • Utilities, such as controlled temperature storage facilities, purified
water, steam, and compressed air, bottled gases • Storage areas for the test and/or control article • Computer and communications networking • Equipment to ensure the safety of staff and the integrity of test
systems and reference standards • Premises designed and equipped to afford maximum protection
against the entry of insects or other animals • Limited or restricted access to prevent the entry of unauthorized
people
Best Quality Practices for Biomedical Research in Drug Development
16
![Page 17: Best Quality Practices for Biomedic Research: Rick Calabrese ASQ 2014 NE Conference](https://reader033.vdocuments.mx/reader033/viewer/2022052601/5597a14f1a28aba7098b46c8/html5/thumbnails/17.jpg)
Test Equipment
• Designed, located and maintained to suit its intended purpose. • Constructed so that surfaces should not be reactive, additive, or
absorptive so as to affect the test method or test results. • Designed so that it can be easily and thoroughly cleaned. • Repair and maintenance operations should not negatively affect
test results. • Installed in such a way as to reduce the likelihood of
contamination. • Defective equipment should, if possible, be removed from active
use.
Best Quality Practices for Biomedical Research in Drug Development
17
![Page 18: Best Quality Practices for Biomedic Research: Rick Calabrese ASQ 2014 NE Conference](https://reader033.vdocuments.mx/reader033/viewer/2022052601/5597a14f1a28aba7098b46c8/html5/thumbnails/18.jpg)
Equipment Design
Best Quality Practices for Biomedical Research in Drug Development
• Equipment shall be suitably located to facilitate operations for its intended use and for its cleaning and maintenance.
• Equipment shall be of adequate size and constructed so that surfaces that contact components, in-process materials, or drug products shall not be reactive, additive, or absorptive so as to alter the safety, identity, strength, quality, or purity of the drug product beyond the official or other established requirements.
• Substances required for operation, such as lubricants or coolants, shall not come into contact with components, drug product containers, closures, in-process materials, or drug products.
• Repair and maintenance should not negatively affect test results.
18
![Page 19: Best Quality Practices for Biomedic Research: Rick Calabrese ASQ 2014 NE Conference](https://reader033.vdocuments.mx/reader033/viewer/2022052601/5597a14f1a28aba7098b46c8/html5/thumbnails/19.jpg)
Calibration
Best Quality Practices for Biomedical Research in Drug Development
• Calibrated, verification through time of use, suitability checks, or both at specific intervals and/or prior to use against measurement standards traceable to international or national measurement standards.
• Labeling of units calibration status and date of recalibration.
• Safeguarded from adjustments that may invalidate the measurement results.
• Protected from damage and deterioration during handling, maintenance, and storage.
19
![Page 20: Best Quality Practices for Biomedic Research: Rick Calabrese ASQ 2014 NE Conference](https://reader033.vdocuments.mx/reader033/viewer/2022052601/5597a14f1a28aba7098b46c8/html5/thumbnails/20.jpg)
Test Methods
• Methods to perform scientific work should be documented to allow for reproducibility.
• They should be clear and easy to understand.
Best Quality Practices for Biomedical Research in Drug Development
20
![Page 21: Best Quality Practices for Biomedic Research: Rick Calabrese ASQ 2014 NE Conference](https://reader033.vdocuments.mx/reader033/viewer/2022052601/5597a14f1a28aba7098b46c8/html5/thumbnails/21.jpg)
Method Validation
• Validation of methods used is critical for the integrity and authenticity of study results.
• Wherever possible, published and generally accepted standard methods should be used.
• Research institutions should confirm and document first that it can properly and reliably operate these standard methods before using them.
• Internally developed methods may also be used if they are appropriate for the intended use, and that documented evidence shows that it meets the appropriate levels of precision, accuracy, repeatability and robustness.
21
![Page 22: Best Quality Practices for Biomedic Research: Rick Calabrese ASQ 2014 NE Conference](https://reader033.vdocuments.mx/reader033/viewer/2022052601/5597a14f1a28aba7098b46c8/html5/thumbnails/22.jpg)
Sampling and Chain of Custody
Best Quality Practices for Biomedical Research in Drug Development
• Adequate and correct sampling is critical for ensuring that the sample taken is a true representative of the whole.
• The research institution should therefore have a sampling plan and procedures for collecting samples of substances, materials, or products for subsequent testing.
• Utilization of sampling (AQL) plans such as ANSI Z1.4
22
![Page 23: Best Quality Practices for Biomedic Research: Rick Calabrese ASQ 2014 NE Conference](https://reader033.vdocuments.mx/reader033/viewer/2022052601/5597a14f1a28aba7098b46c8/html5/thumbnails/23.jpg)
Materials
• Handling, storage and quality of materials used in the conduct of biomedical research can affect the outcome.
• The identity and purity of the material received must meet method specifications.
• Manufacturer identifier (such as lot or batch numbers) • In-house labeling is used to provide traceability • Materials are stored under the appropriate conditions • Usage of the materials is tracked
Best Quality Practices for Biomedical Research in Drug Development
23
![Page 24: Best Quality Practices for Biomedic Research: Rick Calabrese ASQ 2014 NE Conference](https://reader033.vdocuments.mx/reader033/viewer/2022052601/5597a14f1a28aba7098b46c8/html5/thumbnails/24.jpg)
Test Articles, Control Articles, and Test Systems
• The purity, concentration, and stability of test articles and control articles (where used) can greatly affect the outcome and repeatability of a study or an experiment.
• The purity, concentration, stability and storage of test articles and control articles should be specified and evaluated and documented periodically following standard operating procedures.
Best Quality Practices for Biomedical Research in Drug Development
24
![Page 25: Best Quality Practices for Biomedic Research: Rick Calabrese ASQ 2014 NE Conference](https://reader033.vdocuments.mx/reader033/viewer/2022052601/5597a14f1a28aba7098b46c8/html5/thumbnails/25.jpg)
Legal and Ethical Considerations
• Protection of intellectual property • Vendor selection and qualification • Research institutions may outsource a portion of their
research activities to a third party. The subcontracted work may be subject to the research institution’s quality system.
All personnel involved in biomedical research activities are to act in an ethical manner free from research
misconduct, US FDA 42 CFR Part 93
Best Quality Practices for Biomedical Research in Drug Development
25
![Page 26: Best Quality Practices for Biomedic Research: Rick Calabrese ASQ 2014 NE Conference](https://reader033.vdocuments.mx/reader033/viewer/2022052601/5597a14f1a28aba7098b46c8/html5/thumbnails/26.jpg)
Dependencies and Resources
QSBRDD
Technology
Personnel
Other Services
Distribution
Promotion
Best Quality Practices for Biomedical Research in Drug Development
26
![Page 27: Best Quality Practices for Biomedic Research: Rick Calabrese ASQ 2014 NE Conference](https://reader033.vdocuments.mx/reader033/viewer/2022052601/5597a14f1a28aba7098b46c8/html5/thumbnails/27.jpg)
Contributors and Affiliation
George Bernstein MAI Consulting
Rick Calabrese Sartorius-Stedim North America Inc.
Keith Conerly Sodexo
Li-Chung Huang ImClone Systems
Alice Krumenaker CorePharma,
Richard Lombardi Forest Research Institute
June Morita Consultant
Juli Moticka Regeneron
Ülo Palm Forest Research Institute
Michele Pruett MLP GXP Solutions LLC
Sandra R. Storli Abbott
John Surak Clemson University and Consultant
Mark Trotter Trotter Biotech Solutions
27
![Page 28: Best Quality Practices for Biomedic Research: Rick Calabrese ASQ 2014 NE Conference](https://reader033.vdocuments.mx/reader033/viewer/2022052601/5597a14f1a28aba7098b46c8/html5/thumbnails/28.jpg)
Looking Ahead...
• When is the next milestone?
• What are the expected deliverables?
• Known risks and issues
• What is the timeline for these issues?
• What are the immediate next steps?
Best Quality Practices for Biomedical Research in Drug Development
28
![Page 29: Best Quality Practices for Biomedic Research: Rick Calabrese ASQ 2014 NE Conference](https://reader033.vdocuments.mx/reader033/viewer/2022052601/5597a14f1a28aba7098b46c8/html5/thumbnails/29.jpg)
Purchase a Copy of the Technical Report
● If you would like to purchase a copy of the Technical Report,
please visit the ASQ website under the Quality Press section:
http://asq.org/quality-press/
Best Quality Practices for Biomedical Research in Drug Development
29
![Page 30: Best Quality Practices for Biomedic Research: Rick Calabrese ASQ 2014 NE Conference](https://reader033.vdocuments.mx/reader033/viewer/2022052601/5597a14f1a28aba7098b46c8/html5/thumbnails/30.jpg)
Join the Committee
• If you would like to find out more information about the standard or
to join the committee, please contact:
Rick Calabrese at [email protected]
or
Alice Krumenaker at [email protected]
Best Quality Practices for Biomedical Research in Drug Development
30
![Page 31: Best Quality Practices for Biomedic Research: Rick Calabrese ASQ 2014 NE Conference](https://reader033.vdocuments.mx/reader033/viewer/2022052601/5597a14f1a28aba7098b46c8/html5/thumbnails/31.jpg)
Thank You!
31